痴呆症中的质细胞:从细胞功能障碍到治疗前沿
1Khulna University of Engineering and Technology, Khulna, Bangladesh.
Cell transplantation
|February 16, 2026
概括
质细胞,不仅仅是神经元,是痴呆症的核心. 本综述整合了质的作用和治疗策略,突出了它们作为治疗阿尔茨海默氏症等神经退行性疾病的关键点的潜力.
科学领域:
- 神经科学是一个神经科学.
- 细胞生物学 细胞生物学
- 病理学 病理学 病理学
背景情况:
- 痴呆症研究传统上专注于神经元.
- 质细胞 (星球细胞,微质细胞,寡质细胞) 在痴呆的发病和进展中起着关键作用.
- 之前的审查单独检查了质功能障碍.
研究的目的:
- 在痴呆症中提供质子类型角色的综合框架.
- 用先进的技术重新定义质异质性和功能.
- 探索特定于质细胞的治疗策略.
主要方法:
- 在单细胞RNA测序的最新进展的综合.
- 空间转录学数据的分析.
- 对质细胞成像技术的审查.
主要成果:
- 质细胞在疾病中表现出复杂的异质性和动态交叉对话.
- 质细胞种群在神经保护和神经退行方面具有双重作用.
- 新兴的质细胞特异性治疗标显示出有前途.
结论:
- 质细胞是痴呆症发病过程中的中央调节器和潜在的守门员.
- 准质路径为痴呆症提供了新的治疗途径.
- 整合质生物学对于痴呆症治疗创新至关重要.
更多相关视频
11:42In vitro Modeling for Neurological Diseases using Direct Conversion from Fibroblasts to Neuronal Progenitor Cells and Differentiation into Astrocytes
Published on: June 10, 2021
5.5K
10:53Generation of Human Neurons and Oligodendrocytes from Pluripotent Stem Cells for Modeling Neuron-Oligodendrocyte Interactions
Published on: November 9, 2020
5.6K
相关概念视频
Glial Cells
94.7K
Overview
94.7K
Nervous Tissue: Glial Cells
7.1K
Glia, or neuroglia, are vital support cells that assist neurons in their functions. The term "glia" originates from the Greek word for "glue," reflecting their role in holding the nervous system together. These cells can be categorized into six types: four in the central nervous system (CNS) and two in the peripheral nervous system (PNS).
The CNS glial cell includes the astrocytes, the oligodendrocytes, the microglia, and the ependymal cells.
Astrocytes are star-shaped glial...
The CNS glial cell includes the astrocytes, the oligodendrocytes, the microglia, and the ependymal cells.
Astrocytes are star-shaped glial...
7.1K
Alzheimer's Disease: Overview
1.8K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.8K
Alzheimer's Disease: Treatment
994
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
994
Dementia
584
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
584
Neurogenesis and Regeneration of Nervous Tissue
1.8K
In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...
1.8K
